Related Experiment Video
Updated: Jan 30, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Bone morphogenetic protein (BMP) 7 expression is regulated by the E3 ligase UBE4A in diabetic nephropathy
Ying Feng1, Ming-Yue Jin1, Dong-Wei Liu2
1Department of Endocrinology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
Abstract:
Mesangial cells played a central role in the pathophysiology of diabetic nephropathy (DN). Our goal was to evaluate the molecular mechanism that regulates loss of BMP7 protein expression in DN. The mRNA and protein levels of BMP7 or UBE4A were detected using qRT-PCR and Western blot respectively. Mass spectrometry and co-immunoprecipitation were used to explore the E3 ligase which regulated BMP7 post-translationally. We initially confirmed that BMP7 protein, but not mRNA, is downregulated when cultured under high glucose mimicking DN conditions, which was rescued by MG-132 treatment. Proteomic analysis of NRK-52E cells ± MG-132 revealed a list of ubiquitin ligases associated with BMP7. Knockdown of the ubiquitin ligase UBE4A stabilized BMP7 expression in NRK-52E cells grown under high glucose conditions. Concurrent overexpression experiments confirmed that UBE4A is the ubiquitin ligase that degrades BMP7. Co-immunoprecipitation analysis confirmed that BMP7 and UBE4A interact. BMP7 expression in DN is regulated by post-translational mechanism.
Insights
Diabetic nephropathy (DN) involves mesangial cells. This study found that the E3 ligase UBE4A targets BMP7 for degradation, explaining BMP7 loss in DN via a post-translational mechanism.
Area of Science:
- Molecular Biology
- Cell Biology
- Nephrology
Background:
- Mesangial cells are critical in diabetic nephropathy (DN) pathogenesis.
- Understanding BMP7 regulation in DN is crucial for therapeutic development.
Purpose of the Study:
- To investigate the molecular mechanism behind Bone Morphogenetic Protein 7 (BMP7) protein loss in DN.
- To identify the specific E3 ligase responsible for BMP7 post-translational regulation.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blotting to assess BMP7 and UBE4A levels.
- Mass spectrometry and co-immunoprecipitation to identify and confirm E3 ligase interaction with BMP7.
- Cell culture under high glucose conditions to mimic DN, with and without proteasome inhibitor MG-132.
Main Results:
- BMP7 protein, not mRNA, decreased in high glucose conditions, indicating post-transcriptional regulation.
- Proteomic analysis identified potential E3 ligases interacting with BMP7.
- Knockdown of UBE4A stabilized BMP7 levels, and overexpression confirmed UBE4A as the ligase degrading BMP7.
- Co-immunoprecipitation verified the interaction between BMP7 and UBE4A.
Conclusions:
- BMP7 protein expression in diabetic nephropathy is regulated by a post-translational mechanism.
- The E3 ligase UBE4A directly targets BMP7 for degradation, contributing to BMP7 deficiency in DN.
- Targeting the UBE4A-BMP7 interaction may offer a therapeutic strategy for diabetic nephropathy.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Covalently Linked Protein Regulators

